Jiangsu Biojetay Biotechnology Co., Ltd.

This study tests a new medicine called STSP-0601 to see how well it stops bleeding in people with hemophilia A or B who have developed inhibitors (antibodies that block standard treatment). About 40 participants aged 12 to 70 will receive the drug during a bleeding episode. The m…